Results 61 to 70 of about 1,329,719 (361)

Multimodal Imaging and Biomarkers in Cardiac Amyloidosis

Diagnostics, 2022
Amyloidosis is a progressive infiltrative disease instigated by the extracellular deposition of amyloid fibrils in various organs such as the heart, kidney, and peripheral nerves.
M. Jung, Suyon Chang, E. Han, J. Youn
semanticscholar   +1 more source

Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis [PDF]

, 2016
Amyloid light-chain (LC) amyloidosis (AL amyloidosis) is a rare and fatal disease for which there are no approved therapies. In patients with AL amyloidosis, LC aggregates progressively accumulate in organs, resulting in organ failure that is ...
Ando, Y, Comenzo, RL, Dispenzieri, A, Gertz, MA, Grogan, M, Lousada, I, Maurer, MS, Merlini, G, Palladini, G, Sanchorawala, V, Wechalekar, A   +10 more
core   +1 more source

Heart transplantation in primary amyloidosis [PDF]

, 2009
Cardiac amyloidosis is a disease with a gloom life expectance after the beginning of the symptomatic phase, usually with sudden death as the final event.
Baumgratz, José Francisco, D'andretta, Carlos, Fonseca, Luciana Da, Guilhen, Claudia Jesus, Leite, Weverton Ferreira, Silva, José Pedro Da, Tângari Junior, Américo, Vila, José Henrique Andrade   +7 more
core   +3 more sources

Cardiac amyloidosis: a review of the literature

Acta Cardiologica, 2022
Cardiac amyloidosis is a rare disease associated with severe morbidity and mortality. There are three main types of amyloidosis associated with cardiac involvement: light chain (AL), familial or senile (ATTR) and secondary amyloidosis (AA).
Nils de Marneffe, R. Dulgheru, A. Ancion, M. Moonen, P. Lancellotti   +4 more
semanticscholar   +1 more source

Cardiac amyloidosis presenting as recurrent acute coronary syndrome with unobstructed coronary arteries: Case report

Indian Heart Journal, 2015
Amyloidosis is a systemic disorder characterized by the deposition of mis-folded protein molecules within various organs. Cardiac involvement may be the presenting feature of this condition or may be identified incidentally during investigation for ...
Anish George, Brian McClements
doaj   +1 more source

Case Report: Diagnosis of Dual-Biopsy Negative Severe Cardiac Amyloidosis [PDF]

, 2016
INTRODUCTION Amyloidosis is a rare disorder that involves the deposition of misfolded protein in extracellular tissue. Disease manifestations vary depending on the affected organs.
Kasprowicz, MD, Eric, Lohr, MD, Kristin
core   +2 more sources

Incidence and survival of transthyretin amyloid cardiomyopathy from a French nationwide study of in- and out-patient databases

Orphanet Journal of Rare Diseases, 2023
Background Precise data about ATTR-CM incidence rates at national level are scarce. Consequently, this study aimed to estimate the annual incidence and survival of transthyretin amyloid cardiomyopathy (ATTR-CM) in France between 2011 and 2019 using real ...
Thibaud Damy, Guillaume Bourel, Michel Slama, Vincent Algalarrondo, Olivier Lairez, Pauline Fournier, Jérôme Costa, Françoise Pelcot, Agnès Farrugia, Isabelle Durand Zaleski, Hervé Lilliu, Caroline Rault, Mathilde Bartoli, Stéphane Fievez, Anna Granghaud, Jeremie Rudant, Agathe Coste, Charlotte Noirot Cosson, Pierre-Alexandre Squara, Marion Narbeburu, Bertrand De Neuville, Philippe Charron   +21 more
doaj   +1 more source

SGLT-2 inhibitors for cardiac amyloidosis: Hype or hope? [PDF]

Eur J Clin Invest
European Journal of Clinical Investigation, Volume 55, Issue 11, November 2025.
Tangianu F, Nicolini E, Dentali F, Bonaventura A.   +3 more
europepmc   +2 more sources

Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy [PDF]

, 2015
Background: Hypertrophic cardiomyopathy (HCM) is a common cardiac disease caused by a range of genetic and acquired disorders. The most common cause is genetic variation in sarcomeric proteins genes.
Rosmini, Stefania <1981>
core   +1 more source

Circulating biomarkers in diagnosis and management of cardiac amyloidosis: a review for internist

Internal and Emergency Medicine, 2022
Cardiac amyloidosis (CA) is due to extracellular myocardial deposition of misfolded proteins resulting in severe cardiac dysfunction and death. The precursors of amyloid fibrils, able of determining a relevant cardiac infiltration, are immunoglobulin ...
F. Perfetto, M. Zampieri, C. Fumagalli, Marco Allinovi, F. Cappelli   +4 more
semanticscholar   +1 more source